Cambridge, Massachusetts-- (Newsfile Corp. - March 10, 2026) - R3 Bio announced the release of its 2026 research report outlining early-stage progress in developing integrated, stem cell-derived ...

In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...

The U.S. Food and Drug Administration (FDA) announced its plans to end the mandatory animal testing of new drugs, a move that sent AI-enabled biotech companies such as Recursion Pharmaceuticals Inc.

Add Yahoo as a preferred source to see more of our stories on Google. Futuristic Technology in medical concept to finding corona virus covid 19 by using ai artificial intelligence, machine learning, ...